The expression file is data/realbenchmark/3.txt
The interested output is: 
cRAF
List of all species:
{'BAX', 'RPS6', 'p53', 'ERBB3', 'TSC2', 'CyclinD1', 'PTEN', 'GSK3a_b', 'CyclinB1', 'ERK1_2', 'Nfkb', 'RB', 'ERBB2', 'p70S6K', 'AKT', 'cRAF', 'FoxO1_3a', 'cJUN', 'pertuzumab', 'PRAS', 'p38', 'ERBB1', 'stimulus', 'trastuzumab', 'erlotinib'}
-----Input names-----
{'pertuzumab', 'erlotinib', 'stimulus', 'trastuzumab'}
----Intermediate nodes-----
{'p70S6K', 'BAX', 'RPS6', 'p53', 'ERBB3', 'TSC2', 'AKT', 'cRAF', 'CyclinD1', 'FoxO1_3a', 'cJUN', 'PTEN', 'PRAS', 'p38', 'GSK3a_b', 'CyclinB1', 'ERBB1', 'ERK1_2', 'Nfkb', 'RB', 'ERBB2'}
Now arrange layout of the original network for visualization
INPUT NAMES LIST:
['erlotinib', 'pertuzumab', 'stimulus', 'trastuzumab']
Sorted input names
['erlotinib', 'pertuzumab', 'stimulus', 'trastuzumab']
There are 4 inputs with the range of input: 0 15
Sorted internames:
['AKT', 'BAX', 'CyclinB1', 'CyclinD1', 'ERBB1', 'ERBB2', 'ERBB3', 'ERK1_2', 'FoxO1_3a', 'GSK3a_b', 'Nfkb', 'PRAS', 'PTEN', 'RB', 'RPS6', 'TSC2', 'cJUN', 'cRAF', 'p38', 'p53', 'p70S6K']
There are 21 intermediate nodes with the range of inter: 0 2097151
----Generate table from output----
======Time for SIMULATING ORIGINAL NETWORK : 0.021120786666870117 seconds===
----Input knockout shapley value-----
('pertuzumab', 0.0)
('erlotinib', 0.0)
('stimulus', 0.0)
('trastuzumab', 0.0)
----Input knockIN shapley value-----
('pertuzumab', 0.0)
('erlotinib', 0.0)
('stimulus', 0.0)
('trastuzumab', 0.0)
-------Now perform the knockout procedure to original network-------
Knockout p70S6K
Knockout BAX
Knockout RPS6
Knockout p53
Knockout ERBB3
Knockout TSC2
Knockout AKT
Knockout CyclinD1
Knockout FoxO1_3a
Knockout cJUN
Knockout PTEN
Knockout PRAS
Knockout p38
Knockout GSK3a_b
Knockout CyclinB1
Knockout ERBB1
Knockout ERK1_2
Knockout Nfkb
Knockout RB
Knockout ERBB2
----KNOCKOUT VALUE for output cRAF----
{'AKT': 0.0, 'BAX': 0.0, 'CyclinB1': 0.0, 'CyclinD1': 0.0, 'ERBB1': 0.0, 'ERBB2': 0.0, 'ERBB3': 0.0, 'ERK1_2': -0.4167, 'FoxO1_3a': 0.0, 'GSK3a_b': 0.0, 'Nfkb': 0.0, 'PRAS': 0.0, 'PTEN': 0.0, 'RB': 0.0, 'RPS6': 0.0, 'TSC2': 0.0, 'cJUN': 0.0, 'p38': 0.0, 'p53': 0.0, 'p70S6K': 0.0}


-------Now perform the KNOCKIN procedure to intermediate nodes-------
Knockin p70S6K
Knockin BAX
Knockin RPS6
Knockin p53
Knockin ERBB3
Knockin TSC2
Knockin AKT
Knockin CyclinD1
Knockin FoxO1_3a
Knockin cJUN
Knockin PTEN
Knockin PRAS
Knockin p38
Knockin GSK3a_b
Knockin CyclinB1
Knockin ERBB1
Knockin ERK1_2
Knockin Nfkb
Knockin RB
Knockin ERBB2
----KNOCKIN VALUE for output cRAF----
{'AKT': 0.0, 'BAX': 0.0, 'CyclinB1': 0.0, 'CyclinD1': 0.0, 'ERBB1': 0.0, 'ERBB2': 0.0, 'ERBB3': 0.0, 'ERK1_2': 0.0, 'FoxO1_3a': 0.0, 'GSK3a_b': 0.0, 'Nfkb': 0.0, 'PRAS': 0.0, 'PTEN': 0.0, 'RB': 0.0, 'RPS6': 0.0, 'TSC2': 0.0, 'cJUN': 0.0, 'p38': 0.0, 'p53': 0.0, 'p70S6K': 0.0}


original.html
----------WITH ACYCLIC FLAG-------------
-------------Now convert the acyclic network to the binary network---------------


-------WORKING WITH BINARY NETWORK-------
----THIS ONLY WORKS FOR ACYCLIC NETWORK------
Input are {'pertuzumab', 'erlotinib', 'stimulus', 'trastuzumab'}
Ordinary nodes are 
{'BAX', 'RPS6', 'p53', 'ERBB3', 'TSC2', 'CyclinD1', 'PTEN', 'GSK3a_b', 'CyclinB1', 'ERK1_2', 'Nfkb', 'RB', 'ERBB2', 'p70S6K', 'AKT', 'cRAF', 'FoxO1_3a', 'cJUN', 'pertuzumab', 'PRAS', 'p38', 'ERBB1', 'stimulus', 'trastuzumab', 'erlotinib'}
Extranodes added after removing cycles are 
['BAX_to_BAX', 'RPS6_to_RPS6', 'p53_to_p53', 'p53_to_GSK3a_b', 'ERBB3_to_ERBB3', 'ERBB3_to_AKT', 'TSC2_to_TSC2', 'CyclinD1_to_CyclinD1', 'PTEN_to_PTEN', 'GSK3a_b_to_CyclinD1', 'GSK3a_b_to_GSK3a_b', 'GSK3a_b_to_PTEN', 'CyclinB1_to_CyclinB1', 'CyclinB1_to_p53', 'ERK1_2_to_ERK1_2', 'Nfkb_to_Nfkb', 'RB_to_RB', 'ERBB2_to_ERBB2', 'ERBB2_to_AKT', 'p70S6K_to_RPS6', 'p70S6K_to_p70S6K', 'AKT_to_AKT', 'cRAF_to_ERK1_2', 'cRAF_to_cRAF', 'FoxO1_3a_to_FoxO1_3a', 'cJUN_to_cJUN', 'PRAS_to_PRAS', 'p38_to_p38', 'ERBB1_to_ERBB1']
binary.html
----Simulate binary network----
INPUT NAMES LIST:
['erlotinib', 'pertuzumab', 'stimulus', 'trastuzumab']
----Generate table from output----
-----Calculated value of input nodes-----
erlotinib            			 KO:        0.0 | KI:        0.0
pertuzumab           			 KO:        0.0 | KI:        0.0
stimulus             			 KO:        0.0 | KI:        0.0
trastuzumab          			 KO:        0.0 | KI:        0.0
=======PROPAGATE FOR OUTPUT cRAF=======
----Master diamonds-----
{'_XTR_17_': 'cRAF', 'ERK1_2': 'cRAF', '_XTR_22_': 'cRAF', '_XTR_24_': 'cRAF', 'stimulus': 'cRAF', '_XTR_56_': 'ERBB2'}


--------PROPAGATION WITH CYCLIC NETWORK--------
IN CYCLIC NETWORK: COMPARE ROWS PROPAGTED TO INPUT NODES AND BASELINE TO ESTIMATE ERROR
AVE_CORRECT_ROWS_INPUT: 0.9062
=========================
PROPAGATED VALUES:
ERBB1                			 KO:        0.0 | KI:    -4.5835
ERBB2                			 KO:        0.0 | KI:    -4.5835
ERK1_2               			 KO:    -0.4167 | KI:        0.0
cRAF                 			 KO:        0.0 | KI:    -5.0002
erlotinib            			 KO:        0.0 | KI:        0.0
pertuzumab           			 KO:        0.0 | KI:        0.0
stimulus             			 KO:        0.0 | KI:        0.0
trastuzumab          			 KO:        0.0 | KI:        0.0
KO RANKING OF NODES:
1	ERK1_2
2	cRAF, ERBB2, ERBB1
=======
KI RANKING OF NODES:
1	cRAF
2	ERBB2, ERBB1
3	ERK1_2, pertuzumab, erlotinib, stimulus, trastuzumab
=======
NUMBER OF NODES: 25
NUMBER OF INPUTS: 4
NUMBER OF EDGES: 70
TIME process heading: 0.0016338825225830078
TIME simulate original network: 0.021120786666870117
TIME perform original analysis process: 0.952768087387085
TIME perform propagation: 0.39729905128479004
There are 17 unreachable nodes, they are:
{'p70S6K', 'BAX', 'RPS6', 'p53', 'ERBB3', 'TSC2', 'AKT', 'CyclinD1', 'FoxO1_3a', 'cJUN', 'PTEN', 'PRAS', 'p38', 'GSK3a_b', 'CyclinB1', 'Nfkb', 'RB'}
ERBB1                - Correct: KO:        0.0 | KI :        0.0 - Incorrect KO:        0.0 | KI:    -4.5835
ERBB2                - Correct: KO:        0.0 | KI :        0.0 - Incorrect KO:        0.0 | KI:    -4.5835
AKT
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

BAX
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

CyclinB1
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

CyclinD1
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

ERBB1
Lack      0: []
Extra    14: [0, 1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]
Real      0: []
Prop     14: [0, 1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]

ERBB2
Lack      0: []
Extra    14: [0, 1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]
Real      0: []
Prop     14: [0, 1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]

ERBB3
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

ERK1_2
Lack      0: []
Extra     0: []
Real      2: [2, 3]
Prop      2: [2, 3]

FoxO1_3a
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

GSK3a_b
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

Nfkb
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

PRAS
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

PTEN
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

RB
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

RPS6
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

TSC2
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

cJUN
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

erlotinib
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

p38
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

p53
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

p70S6K
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

pertuzumab
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

stimulus
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

trastuzumab
Lack      0: []
Extra     0: []
Real      0: []
Prop      0: []

-----KO RANKING COMPARISON-----
1	ERK1_2
2	ERBB2, ERBB1, pertuzumab, erlotinib, stimulus, trastuzumab
	p70S6K, BAX, RPS6, p53, ERBB3, TSC2
	AKT, CyclinD1, FoxO1_3a, cJUN, PTEN, PRAS
	p38, GSK3a_b, CyclinB1, Nfkb, RB
REFERENCE:
1	ERK1_2
2	pertuzumab, erlotinib, stimulus, trastuzumab, p70S6K, BAX
	RPS6, p53, ERBB3, TSC2, AKT, CyclinD1
	FoxO1_3a, cJUN, PTEN, PRAS, p38, GSK3a_b
	CyclinB1, ERBB1, Nfkb, RB, ERBB2
=======
-----KI RANKING COMPARISON-----
1	ERBB2, ERBB1
2	ERK1_2, pertuzumab, erlotinib, stimulus, trastuzumab, p70S6K
	BAX, RPS6, p53, ERBB3, TSC2, AKT
	CyclinD1, FoxO1_3a, cJUN, PTEN, PRAS, p38
	GSK3a_b, CyclinB1, Nfkb, RB
REFERENCE:
1	pertuzumab, erlotinib, stimulus, trastuzumab, p70S6K, BAX
	RPS6, p53, ERBB3, TSC2, AKT, CyclinD1
	FoxO1_3a, cJUN, PTEN, PRAS, p38, GSK3a_b
	CyclinB1, ERBB1, ERK1_2, Nfkb, RB, ERBB2
============
Relative_RMSE_KO_is  0.0
Relative_RMSE_KI_is  0.1323142479415325
NDCG_KO_is  1.0
NDCG_KI_is  0.0

Ranking Comparison
==================
Metric                                   KO           KI
----------------------------------------------------------
n_common                             24.000       24.000
Kendall tau-b                         1.000          NaN
Spearman rho                          1.000        0.000
Mean abs rank diff                    0.000        0.917
----------------------------------------------------------

Top-r Overlap:
  Top-10 Jaccard                   1.000        1.000
         Precision@10                1.000        1.000
         Recall@10                   1.000        1.000
  Top-20 Jaccard                   1.000        1.000
         Precision@20                1.000        1.000
         Recall@20                   1.000        1.000
----------------------------------------------------------

Top-group Overlap:
  Top-1  groups Jaccard            1.000        0.083
  Top-2  groups Jaccard            1.000        1.000
  Top-3  groups Jaccard            1.000        1.000
==========================================================
AVERAGE_CORRECT_ROWS_ALL_NODES:  0.9271
-----------TOTAL RUNNING TIME---------------
1.5298970420844853
